<DOC>
	<DOCNO>NCT02466113</DOCNO>
	<brief_summary>Whether patient stage II colon cancer receive adjuvant chemotherapy still debate.MicroRNA ( miRNA ) promise tool . Investigators invent tool consist 6 miRNA ( miR-21、miR-20a-5p、miR-103a-3p、miR-106b-5p、miR-143-5p miR-215 ) effective identify one accept adjuvant chemotherapy . Here investigator randomly assign patient assess classical pathological feature miRNA tool determine accept chemotherapy . Disease free survival overall survival end point observation .</brief_summary>
	<brief_title>A 6 microRNA Tool Stratifying Stage II Colon Cancer Receiving Adjuvant Chemotherapy</brief_title>
	<detailed_description>Investigators randomly assign patient assess classical pathological feature ( control group ) miRNA tool ( experimental group ) . Pathological feature include poorly differentiate histology ( exclusive cancer MSI-H ) , lymphatic/vascular invasion , bowel obstruction &lt; 12 lymph node examined.MicroRNA tool contains miRNA miR-21、miR-20a-5p、miR-103a-3p、miR-106b-5p、miR-143-5p miR-215 . Investigators evaluate miRNA status surgical specimen use qRT-PCR calculate risk score ( risk score = ( 0.108×status miR-21-5p ) + ( 0.086×status miR-20a-5p ) + ( 0.240×status miR-103a-3p ) + ( 0.095×status miR-106b-5p ) - ( 0.238×status miR-143-5p ) - ( 0.237×status miR-215 ) , low expression status equal 0 high expression status equal 1 ) . Investigators define high risk patient pathological feature control group score large 1 experimental group , others low risk patient.The high risk group receive adjuvant chemotherapy low risk group deserve observation . Primary endpoint disease free survival overall survival .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>The informed consent obtain patient . With confirmed diagnosis stage II colon cancer . With moderate/good ECOG health rating ( PS ) : 01 score . The patient receive anticancer treatment primary surgery . The patient receive radical operation colon cancer negative margin . With severe comorbidities , cardiovascular disease , chronic obstructive pulmonary disease , diabetes mellitus , chronic renal dysfunction . With bad compliance contraindication enrollment . Pregnant woman lactate woman . With contraindication receive adjuvant chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>